Management of hemangiomas and other vascular tumors

Clinics in Plastic Surgery

Volumn 38, Issue 1, 2011, Pages 45-63

  Greene, Arin K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hemangioma; Kaposiform hemangioendothelioma; Pyogenic granuloma; Vascular anomaly; Vascular tumor

Indexed keywords

CORTICOSTEROID; INTERFERON; ORAPRED; PREDNISOLONE; PROPRANOLOL; TRIAMCINOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ANTIANGIOGENIC ACTIVITY; ARTIFICIAL EMBOLISM; BLINDNESS; BRADYCARDIA; CATARACT; CLINICAL FEATURE; CLINICAL OBSERVATION; CONGENITAL HEMANGIOMA; CONGESTIVE HEART FAILURE; DERMATOMYCOSIS; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; EXCISION; FEMUR HEAD NECROSIS; GLAUCOMA; HEMANGIOMA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INFANTILE HEMANGIOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; LIPOATROPHY; LIVER HEMANGIOMA; LOW LEVEL LASER THERAPY; LUMBOSACRAL HEMANGIOMA; MOON FACE; MYOPATHY; NONINVOLUTING CONGENITAL HEMANGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PERSONALITY DISORDER; PYOGENIC GRANULOMA; RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA; RETICULAR HEMANGIOMA; REVIEW; SCLEROTHERAPY; SIDE EFFECT; STOMACH IRRITATION; SURGICAL TECHNIQUE; TRACHEOSTOMY; TREATMENT INDICATION; VASCULAR SURGERY; VASCULAR TUMOR; WOUND CARE;

CHILD, PRESCHOOL; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASMS, VASCULAR TISSUE;

EID: 78649254544     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2010.08.001     Document Type: Review

References (98)

1. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-422.
2. Finn M.C., Glowacki J., Mulliken J.B. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983, 18:894-900.
3. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr Scand 1955, 44:370-379.
4. Jacobs A.H., Walton R.G. The incidence of birthmarks in the neonate. J Pediatr 1976, 58:218-222.
5. Kilcline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008, 25:168-173.
6. Amir J., Metzker A., Krikler R., et al. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986, 3:331-332.
7. Drolet B.A., Swanson E.A., Frieden I.J. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008, 153:712-715.
8. Mulliken J.B., Fishman S.J., Burrows P.E. Vascular anomalies. Curr Probl Surg 2000, 37:517-584.
9. Chang L.C., Haggstrom A.N., Drolet B.A., et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008, 122:360-367.
10. Bowers R.E., Graham E.A., Tomlinson K.M. The natural history of the strawberry nevus. Arch Dermatol 1960, 82:667-680.
11. Paltiel H., Burrows P.E., Kozakewich H.P.W., et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000, 214:747-754.
12. Burrows P.E., Laor T., Paltiel H., et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998, 16:455-488.
13. Meyer J.S., Joffer F.A., Barnes P.D., et al. Biological classification of soft-tissue vascular anomalies: MR correlation. Am J Roentgenol 1991, 157:559-564.
14. Jones E.W., Orkin M. Tufted angioma (angioblastoma): a benign progressive angioma, not to be confused with Kaposi's sarcoma or low grade angiosarcoma. J Am Acad Dermatol 1989, 20:214-225.
15. Chung K.C., Weiss S.W., Kuzon W.M. Multifocal congenital hemangiopericytomas associated with Kasabach-Merritt syndrome. Br J Plast Surg 1995, 48:240-242.
16. Boon L.M., Fishman S.J., Lund D.P., et al. Congenital fibrosarcoma masquerading as congenital hemangioma: report of two cases. J Pediatr Surg 1995, 30:1378-1381.
17. Tan W.H., Baris H.N., Burrows P.E., et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 2007, 44:594-602.
18. Merrell S.C., Rahbar R., Alomari A.I., et al. Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions. J Craniofac Surg 2010, 21:422-426.
19. North P.E., Waner M., Mizeracki A., et al. GLUT1. A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000, 31:11-22.
20. Enjolras O., Gelbert F. Superficial hemangiomas: associations and management. Pediatr Dermatol 1997, 14:173-179.
21. Sie K.C., McGill T., Healy G.B. Subglottic hemangioma: ten years experience with carbon dioxide laser. Ann Otol Rhinol Laryngol 1994, 103:167-172.
22. Rahbar R., Nicollas R., Roger G., et al. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope 2004, 114:1880-1891.
23. Christison-Lagay E.R., Burrows P.E., Alomari A., et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007, 42:62-67.
24. Boon L.M., Burrows P.E., Paltiel H.J., et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996, 129:346-354.
25. Huang S.A., Tu H.M., Harney J.W., et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000, 343:185-189.
26. Mulliken J.B., Marler J.J., Burrows P.E., et al. Reticular infantile hemangioma of the limb can be associated with ventral-caudal anomalies, refractory ulceration, and cardiac overload. Pediatr Dermatol 2007, 24:356-362.
27. Goldberg N.S., Hebert A.A., Esterly N.B. Sacral hemangiomas and multiple congenital anomalies. Arch Dermatol 1986, 122:684-687.
28. Albright A.L., Gartner J.C., Wiener E.S. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989, 83:977-980.
29. Bouchard S., Yazbeck S., Lallier M. Perineal hemangioma, anorectal malformation, and genital anomaly: a new association?. J Pediatr Surg 1999, 34:1133-1135.
30. Girard C., Bigorre M., Guillot B., et al. PELVIS syndrome. Arch Dermatol 2006, 142:884-888.
31. Stockman A., Boralevi F., Taieb A., et al. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urological anomalies, associated with an angioma of lumbosacral localization. Dermatology 2007, 214:40-45.
32. Freiden I.J., Reese V., Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996, 132:307-311.
33. Metry D.W., Haggstrom A.N., Drolet B.A., et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet 2006, 140A:975-986.
34. Metry D.W., Garzon M.C., Drolet B.A., et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009, 26:381-398.
35. Chamlin S.L., Haggstrom A.N., Drolet B.A., et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007, 151:684-689.
36. Elsas F.J., Lewis A.R. Topical treatment of periocular capillary hemangioma. Strabismus 1994, 31:153-156.
37. Cruz O.A., Zarnegar S.R., Myers S.E. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology 1995, 102:2012-2015.
38. Garzon M.C., Lucky A.W., Hawrot A., et al. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol 2005, 52:281-286.
39. Gilbertson E.O., Spellman M.C., Piacquadio D.J., et al. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998, 38:318-321.
40. Crum R., Szabo S., Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985, 230:1375-1378.
41. Sloan G.M., Renisch J.F., Nichter L.S., et al. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg 1989, 83:459-467.
42. Ruttum M.S., Abrams G.W., Harris G.J., et al. Bilateral retinal embolization associated with intralesional steroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993, 30:4-7.
43. Egbert J.E., Schwartz G.S., Walsh A.W. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 1996, 121:638-642.
44. Goyal R., Watts P., Lane C.M., et al. Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma. Ophthalmology 2004, 111:389-395.
45. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008, 358:2649-2651.
46. Sans V., Dumas de la Roque E., Berge J., et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009, 124:423-431.
47. Lawley L.P., Siegfried E., Todd J.L. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009, 26:610-614.
48. Frieden I.L., Drolet B.A. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 2009, 26:642-644.
49. Zarem H.A., Edgerton M.T. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967, 39:76-83.
50. Boon L.M., MacDonald D.M., Mulliken J.B. Complications of systemic corticosteroid therapy for problematic hemangiomas. Plast Reconstr Surg 1999, 104:1616-1623.
51. Bennett M.L., Fleischer A.B., Chamlin S.L., et al. Oral corticosteroid use is effective for cutaneous hemangiomas. Arch Dermatol 2001, 137:1208-1213.
52. Greene A.K. Corticosteroid treatment for problematic infantile hemangioma: evidence does not support an increased risk for cerebral palsy. Pediatrics 2008, 126:1251-1252.
53. Greene A.K. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma. Pediatr Dermatol 2010, 27:322-323.
54. Greene A.K., Rogers G., Mulliken J.B. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 2004, 113:53-60.
55. Sadan N., Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 1996, 128:141-146.
56. Moore J., Lee M., Garzon M., et al. Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg 2001, 36:1273-1276.
57. Haisley-Royster C., Enjolras O., Frieden I.J., et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002, 24:459-462.
58. Fawcett S.L., Grant I., Hall P.N., et al. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004, 57:168-171.
59. Enjolras O., Breviere G.M., Roger G., et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004, 11:99-107.
60. Barlow C.F., Priebe C., Mulliken J.B., et al. Spastic diplegia as a complication of interferon-alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998, 132:527-530.
61. Dubois J., Hershon L., Carmant L., et al. Toxicity profile of interferon-alfa-2b in children: a prospective evaluation. J Pediatr 1999, 135:782-785.
62. Michaud A.P., Bauman N.M., Burke D.K., et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004, 114:1231-1236.
63. Lomenick J.P., Backeljauw P.F., Lucky A.W. Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-a retrospective study. Pediatr Dermatol 2006, 23:169-174.
64. George M.E., Sharma V., Jacobson J., et al. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004, 140:963-969.
65. Seale J.P., Compton M.R. Side-effects of corticosteroid agents. Med J Aust 1986, 144:139-142.
66. Fardet L., Abdulrhaman K., Cabane J., et al. Corticosteroid-induced adverse events in adults. Drug Saf 2007, 30:861-881.
67. Lomenick J.P., Reifschneider K.L., Lucky A.W., et al. Prevalence of adrenal insufficiency following systemic gluocorticoid therapy in infants with hemangiomas. Arch Dermatol 2009, 145:262-266.
68. Scheepers J.H., Quaba A.A. Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas: observations based on 3 years experience. Plast Reconstr Surg 1995, 95:305-312.
69. Batta K., Goodyear H.M., Moss C., et al. Randomized controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002, 360:521-527.
70. Witman P.M., Wagner A.M., Scherer K., et al. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 2006, 38:116-123.
71. Scarcella J.V., Dykes E.R., Anderson R. Hemangiomas of the parotid gland. Plast Reconstr Surg 1965, 36:38-47.
72. Williams H.B. Hemangiomas of the parotid gland in children. Plast Reconstr Surg 1975, 56:29-34.
73. Little K.E., Cywes S., Davies M.R., et al. Complicated giant hemangioma: excision using cardiopulmonary bypass and deep hypothermia. J Pediatr Surg 1976, 11:533-536.
74. Tiret L., Nivoche Y., Hatton F., et al. Complications related to anesthesia in infants and children. Br J Anaesth 1988, 61:263-269.
75. Cohen M.M., Cameron C.B., Duncan P.G. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg 1990, 70:160-167.
76. Tay C.L., Tan G.M., Ng S.A. Critical incidents in paediatric anaesthesia: an audit of 1000 anaesthetics in Singapore. Paediatr Anaesth 2001, 11:711-718.
77. Murat I., Constant I., Maudhuy H. Perioperative anaesthetic morbidity in children: database of 24165 anaesthetics over a 30-month period. Paediatr Anaesth 2004, 14:158-166.
78. Charlesworth R. The toddler: affective development. Charlesworth R, editor. Understanding child development 1994, 304. Clifton Park (NY): Delmar Learning. 6th edition.
79. Santrock J.W. The self and identity. Santrock JW, editor. Child development 1996, 378-385. Columbus (OH): McGraw-Hill. 7th edition.
80. Neisser U. Memory development: new questions and old. Dev Rev 2004, 24:154.
81. Mulliken J.B., Rogers G.F., Marler J.J. Circular excision of hemangioma and purse-string closure: the smallest possible scar. Plast Reconstr Surg 2002, 109:1544-1554.
82. Boon L.M., Enjolras O., Mulliken J.B. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996, 128:329-335.
83. Enjolras O., Mulliken J.B., Boon L.M., et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001, 107:1647-1654.
84. Berenguer B., Mulliken J.B., Enjolras O., et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003, 6:495-510.
85. Kasabach H.H., Merritt K.K. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940, 59:1063-1070.
86. Zukerberg L.R., Nikoloff B.J., Weiss S.W. Kaposiform hemangioendothelioma of infancy and childhood: an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993, 17:321-328.
87. Sarkar M., Mulliken J.B., Kozakewich H.P., et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997, 100:1377-1386.
88. Enjolras O., Wassef M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997, 130:631-640.
89. Lyons L.L., North P.E., Mac-Moune Lai F., et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004, 28:559-568.
90. Debelenko L.V., Perez-Atayde A.R., Mulliken J.B., et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005, 18:1454-1460.
91. Mulliken J.B., Anupindi S., Ezekowitz R.A., et al. Case 13-2004: a newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004, 350:1764-1775.
92. Enjolras O., Mulliken J.B., Wassef M., et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000, 42:225-235.
93. Mentzel T., Mazzoleni G., Dei Tos A.P., et al. Kaposiform hemangioendothelioma in adults. Clinicopathologic and immunohistochemical analysis of three cases. Am J Clin Pathol 1997, 108:450-455.
94. Karnes J.C., Lee B.T., Phung T., et al. Adult-onset kaposiform hemangioendothelioma in a post-traumatic site. Ann Plast Surg 2009, 62:456-458.
95. Gruman A., Liang M.G., Mulliken J.B., et al. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol 2005, 52:616-622.
96. Mills S.E., Cooper P.H., Fechner R.E. Lobular capillary hemangioma: the underlying lesion of pyogenic granuloma. Am J Surg Pathol 1980, 4:470-479.
97. Patrice S.J., Wiss K., Mulliken J.B. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol 1991, 8:267-276.
98. Kirschner R.E., Low D.W. Treatment of pyogenic granuloma by shave excision and laser photocoagulation. Plast Reconstr Surg 1999, 104:1346-1349.